Welcome
Rare Disease Connect in Neurology (RDCN) is a long-term learning programme, connecting the MG, TK2d and MOGAD communities committed to delivering excellence for patients living with myasthenia gravis (MG), thymidine kinase 2 deficiency (TK2d) or myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Our mission is to collaborate, educate and inspire through cutting-edge science, expert insight, and lively discussion.
Imagine what we can do for patients, together.
Create an account to join the RDCN community and gain access to on demand content and learn more about upcoming events. Login if you already have an account.
Confirmation is also subject to country-specific compliance and regulatory requirements. Following confirmation, you will receive an email with instructions for accessing the RDCN resources.
